JACQUELINE GARCIA-SANCHEZ: Open Payments
NPI 1588324602 · ALBUQUERQUE, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$299 in 10 payments from 7 companies in 2025. Trend: 2023 $36 · 2024 $324 · 2025 $299
Food & beverage: $299
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 1 | $120 |
| ABBVIE INC. | 4 | $76 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $30 |
| Alkermes, Inc. | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| Braeburn Inc. | 1 | $19 |
| Indivior Inc. | 1 | $14 |
Products named: Yeztugo, MAVYRET, CAPLYTA, VRAYLAR, VIVITROL, ABILIFY MAINTENA, BRIXADI, SUBLOCADE.
Industry payments across NM — which companies pay providers there.
